巨大戟萜醇－３－醯化物ＩＩＩ及巨大戟萜醇－３－胺基甲酸酯化物农业专利-农业专业知识服务系统

发明人:: GRUE-SORENSEN, GUNNAR,格鲁　索伦森　古纳,格魯　索倫森　古納,LIANG, XIFU,梁锡富,梁錫富,HOGBERG, THOMAS,霍伯格　汤玛斯,霍伯格　湯瑪斯,MANSSON, KRISTOFFER,曼森　克理斯多夫,VIFIAN, THOMAS,维富安　汤玛斯,維富安　湯瑪斯,VEDSO, PER,韦德索　佩儿,韋德索　佩兒,格鲁索伦森古纳,格魯索倫森古納,霍伯格汤玛斯,霍伯格湯瑪斯,曼森克理斯多夫,维富安汤玛斯,維富安湯瑪斯,韦德索佩儿,韋德索佩兒

摘要：: The invention relates to compounds of general formula I wherein R is heteroaryl optionally substituted by R7； or R is heterocycloalkyl or heterocycloalkenyl, optionally substituted by R8； or R is X wherein X is -NR11R12； and pharmaceutically acceptable salts, hydrates, or solvates thereof, for use -alone or in combination with one or more other pharmaceutically active compounds- in therapy, for preventing, treating or ameliorating dlseases or conditions responsive to stimulation of neutrophil oxidative burst, responsive to stimulation of keratinocyte IL-8 release or responsive to induction of necrosis.本發明係關於通式I化合物其中R為視情況經R7取代之雜芳基；或R為視情況經R8取代之雜環烷基或雜環烯基；或R為X，其中X為-NR11R12；及其醫藥學上可接受之鹽、水合物或溶劑合物，其係單獨或與一或多種其他醫藥活性化合物組合用於預防、治療或改善對刺激嗜中性白血球氧化爆發起反應、對刺激角質細胞IL-8釋放起反應或對誘導壞死起反應之疾病或病狀之療法中。